NASDAQ
4D Molecular Therapeutics, Inc. (FDMT) has a free cash flow growth of -344.00% as of Friday, May 29, 2026. This represents a 958.96% decrease compared to its 12-month average of 40.05%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.